Biomerica, Inc. (NASDAQ:BMRA – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.36 and traded as low as $0.27. Biomerica shares last traded at $0.33, with a volume of 377,159 shares changing hands.
Biomerica Stock Performance
The firm has a 50 day moving average price of $0.33 and a two-hundred day moving average price of $0.36. The company has a market capitalization of $5.47 million, a P/E ratio of -0.88 and a beta of -1.10.
Biomerica (NASDAQ:BMRA – Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The company had revenue of $1.81 million during the quarter.
Institutional Inflows and Outflows
About Biomerica
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Recommended Stories
- Five stocks we like better than Biomerica
- 5 Top Rated Dividend Stocks to Consider
- Top 3 Investment Themes to Watch for in 2025
- Which Wall Street Analysts are the Most Accurate?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Are Earnings Reports?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.